Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05987059 · ClinicalTrials.gov registry record · Phase 2
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
A Phase 2 study of Preconception Health, sponsored by Morehouse School of Medicine.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 850
- Enrollment target
- 2
- Study locations
NCT05987059: Recruiting Phase 2 study of Preconception Health, sponsored by Morehouse School of Medicine.
NCT05987059 is a Phase 2 study of Preconception Health that is actively recruiting participants, run by Morehouse School of Medicine. The registered enrollment target is 850 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (539% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05987059, a Phase 2 study of Preconception Health, is actively recruiting participants, sponsored by Morehouse School of Medicine.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 850 participants
- Enrollment target
- 2
- Study locations
Study Summary
With support from the National Heart, Lung, and Blood Institute, The Center for Maternal Health Equity at Morehouse School of Medicine is conducting a research study to test the implementation of Pre-Pregnancy Counseling in community-based settings.
Primary Outcome
Each participant will remain in the study for six months and will complete three interviews (baseline, 3-month, 6-month follow-up). The number of pre-conception counseling sessions received by community members in the standard and enhanced intervention arms will be captured at 6 months. The proposed range for the primary implementation outcome will be 0-7 visits/contacts.
Conditions Studied
Interventions
- BEHAVIORAL SBIRT Intervention
Study Locations (2)
Georgia
- Morehouse School of Medicine - Atlanta
- Morehouse School of Medicine - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 850 participants |
| Start Date | 2024-01-01 |
| Est. Completion | 2028-12 |
| Phase | Phase 2 |
What NCT05987059 shows while recruiting
NCT05987059 is an interventional study that assigns participants to a tested intervention. The registered 850 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (539% higher).
The record links to 1 condition, with Preconception Health appearing as the primary indexed condition, and to 1 intervention - of which SBIRT Intervention is the first listed.
NCT05987059 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05987059 about?
NCT05987059 is a clinical study titled "Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT". With support from the National Heart, Lung, and Blood Institute, The Center for Maternal Health Equity at Morehouse School of Medicine is conducting a research study to test the implementation of Pre-Pregnancy Counseling in community-based settings.
What is the current status of trial NCT05987059?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 850 participants. The study started on 2024-01-01. Estimated completion is 2028-12.
What conditions does trial NCT05987059 study?
This clinical trial studies the following conditions: Preconception Health.
What interventions are being tested in trial NCT05987059?
The interventions under investigation include: SBIRT Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05987059?
This trial is sponsored by Morehouse School of Medicine, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05987059 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05987059's enrollment target sits among peer trials
850 35th of 2000 higher than 1,966 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03507257 · 850 participants
Longitudinal Early-onset Alzheimer's Disease Study Protocol
- NCT05846841 · 850 participants · NA
Personalized Tobacco Treatment in Primary Care (MOTIVATE)
- NCT06289673 · 850 participants · Phase 4
Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
- NCT06526195 · 850 participants · NA
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI